PRICING SHEET TEMPLATE - Attachment 1.xlsx
XLSX spreadsheet 27 KB Posted
- Solicitation number
- 15DDHQ24R00000021
About this file
This document is a pricing sheet template for a federal contract opportunity titled "Evaluation of Abuse Potential of Hallucinogenic Substances Using In Vivo Pharmacological Studies" issued by the Drug Enforcement Administration (DEA).
The pricing sheet template covers five ordering periods and includes line items for various assays and costs such as drug discrimination, pharmacokinetic assays, and locomotor assays. The total estimated cost per ordering period is $8,000, with the drug cost not to exceed $500 per ordering period. The related federal contract opportunity solicitation number is 15DDHQ24R00000021, and the description indicates the DEA requires investigational study results and a formal study report on the abuse potential of up to 16 hallucinogenic test substances. The contractor will evaluate a dose response study of two training drugs and reference drugs.
View the file
Other files
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Summary
| PERIOD | Total Cost Per Ordering Period |
| ORDERING PERIOD 1 | |
| ORDERING PERIOD 2 | |
| ORDERING PERIOD 3 | |
| ORDERING PERIOD 4 | |
| ORDERING PERIOD 5 | |
| Total Cost |
ORDERING PERIOD 1
| PRICING SHEET TEMPLATE: ATTACHMENT 1 | |
| Title: | Evaluation of Abuse Potential of Hallucinogenic Substances Using In Vivo Pharmacological Studies |
| Agency: | Drug Enforcement Administration | ||||
| ORDERING PERIOD 1 | |||||
| CLIN Line Item | Assay | Quantity | Unit | Unit Price | Estimated Total Price |
| 0001 | Drug Discrimination (initial training) - Drug 1 - Assay Cost | 4 | EA | 0.00 | |
| 0002 | Drug Discrimination (initial training) - Drug 1 - Incidental Cost | 4 | EA | 0.00 | |
| 0003 | Drug Discrimination (initial training) - Drug 2 - Assay Cost | 4 | EA | 0.00 | |
| 0004 | Drug Discrimination (initial training) - Drug 2 - Incidental Cost | 4 | EA | 0.00 | |
| 0005 | Drug Discrimination (monthly maintenance of training drug) - Drug 1 - Assay Cost | 8 | EA | 0.00 | |
| 0006 | Drug Discrimination (monthly maintenance of training drug) - Drug 1 - Incidental Cost | 8 | EA | 0.00 | |
| 0007 | Drug Discrimination (monthly maintenance of training drug) - Drug 2 - Assay Cost | 8 | EA | 0.00 | |
| 0008 | Drug Discrimination (monthly maintenance of training drug) - Drug 2 - Incidental Cost | 8 | EA | 0.00 | |
| 0009 | Drug Discrimination of Test Drug - Assay Cost | 16 | EA | 0.00 | |
| 0010 | Drug Discrimination of Test Drug - Incidental Cost | 16 | EA | 0.00 | |
| 0011 | Pharmacokinetic Assay - Assay Cost | 10 | EA | 0.00 | |
| 0012 | Pharmacokinetic Assay - Incidental Cost | 10 | EA | 0.00 | |
| 0013 | Locomotor or another dose-finding assay (if applicable) - Assay Cost | 16 | EA | 0.00 | |
| 0014 | Locomotor or another dose-finding assay (if applicable) - Incidental Cost | 16 | EA | 0.00 | |
| 0015 | Drug Cost Not to Exceed | 16 | EA | $500.00 | 8,000.00 |
| TOTAL COST ($) | $8,000.00 |
1 TOTAL
ORDERING PERIOD 2
| PRICING SHEET TEMPLATE: ATTACHMENT 1 | |
| Title: | Evaluation of Abuse Potential of Hallucinogenic Substances Using In Vivo Pharmacological Studies |
| Agency: | Drug Enforcement Administration | ||||
| ORDERING PERIOD 2 | |||||
| CLIN Line Item | Assay | Quantity | Unit | Unit Price | Estimated Total Price |
| 1001 | Drug Discrimination (initial training) - Drug 1 - Assay Cost | 4 | EA | 0.00 | |
| 1002 | Drug Discrimination (initial training) - Drug 1 - Incidental Cost | 4 | EA | 0.00 | |
| 1003 | Drug Discrimination (initial training) - Drug 2 - Assay Cost | 4 | EA | 0.00 | |
| 1004 | Drug Discrimination (initial training) - Drug 2 - Incidental Cost | 4 | EA | 0.00 | |
| 1005 | Drug Discrimination (monthly maintenance of training drug) - Drug 1 - Assay Cost | 8 | EA | 0.00 | |
| 1006 | Drug Discrimination (monthly maintenance of training drug) - Drug 1 - Incidental Cost | 8 | EA | 0.00 | |
| 1007 | Drug Discrimination (monthly maintenance of training drug) - Drug 2 - Assay Cost | 8 | EA | 0.00 | |
| 1008 | Drug Discrimination (monthly maintenance of training drug) - Drug 2 - Incidental Cost | 8 | EA | 0.00 | |
| 1009 | Drug Discrimination of Test Drug - Assay Cost | 16 | EA | 0.00 | |
| 1010 | Drug Discrimination of Test Drug - Incidental Cost | 16 | EA | 0.00 | |
| 1011 | Pharmacokinetic Assay - Assay Cost | 10 | EA | 0.00 | |
| 1012 | Pharmacokinetic Assay - Incidental Cost | 10 | EA | 0.00 | |
| 1013 | Locomotor or another dose-finding assay (if applicable) - Assay Cost | 16 | EA | 0.00 | |
| 1014 | Locomotor or another dose-finding assay (if applicable) - Incidental Cost | 16 | EA | 0.00 | |
| 1015 | Drug Cost Not to Exceed | 16 | EA | $500.00 | 8,000.00 |
| TOTAL COST ($) | $8,000.00 |
ORDERING PERIOD 3
| PRICING SHEET TEMPLATE: ATTACHMENT 1 | |
| Title: | Evaluation of Abuse Potential of Hallucinogenic Substances Using In Vivo Pharmacological Studies |
| Agency: | Drug Enforcement Administration | ||||
| ORDERING PERIOD 3 | |||||
| CLIN Line Item | Assay | Quantity | Unit | Unit Price | Estimated Total Price |
| 2001 | Drug Discrimination (initial training) - Drug 1 - Assay Cost | 4 | EA | 0.00 | |
| 2002 | Drug Discrimination (initial training) - Drug 1 - Incidental Cost | 4 | EA | 0.00 | |
| 2003 | Drug Discrimination (initial training) - Drug 2 - Assay Cost | 4 | EA | 0.00 | |
| 2004 | Drug Discrimination (initial training) - Drug 2 - Incidental Cost | 4 | EA | 0.00 | |
| 2005 | Drug Discrimination (monthly maintenance of training drug) - Drug 1 - Assay Cost | 8 | EA | 0.00 | |
| 2006 | Drug Discrimination (monthly maintenance of training drug) - Drug 1 - Incidental Cost | 8 | EA | 0.00 | |
| 2007 | Drug Discrimination (monthly maintenance of training drug) - Drug 2 - Assay Cost | 8 | EA | 0.00 | |
| 2008 | Drug Discrimination (monthly maintenance of training drug) - Drug 2 - Incidental Cost | 8 | EA | 0.00 | |
| 2009 | Drug Discrimination of Test Drug - Assay Cost | 16 | EA | 0.00 | |
| 2010 | Drug Discrimination of Test Drug - Incidental Cost | 16 | EA | 0.00 | |
| 2011 | Pharmacokinetic Assay - Assay Cost | 10 | EA | 0.00 | |
| 2012 | Pharmacokinetic Assay - Incidental Cost | 10 | EA | 0.00 | |
| 2013 | Locomotor or another dose-finding assay (if applicable) - Assay Cost | 16 | EA | 0.00 | |
| 2014 | Locomotor or another dose-finding assay (if applicable) - Incidental Cost | 16 | EA | 0.00 | |
| 2015 | Drug Cost Not to Exceed | 16 | EA | $500.00 | 8,000.00 |
| TOTAL COST ($) | $8,000.00 |
ORDERING PERIOD 4
| PRICING SHEET TEMPLATE: ATTACHMENT 1 | |
| Title: | Evaluation of Abuse Potential of Hallucinogenic Substances Using In Vivo Pharmacological Studies |
| Agency: | Drug Enforcement Administration | ||||
| ORDERING PERIOD 4 | |||||
| CLIN Line Item | Assay | Quantity | Unit | Unit Price | Estimated Total Price |
| 3001 | Drug Discrimination (initial training) - Drug 1 - Assay Cost | 4 | EA | 0.00 | |
| 3002 | Drug Discrimination (initial training) - Drug 1 - Incidental Cost | 4 | EA | 0.00 | |
| 3003 | Drug Discrimination (initial training) - Drug 2 - Assay Cost | 4 | EA | 0.00 | |
| 3004 | Drug Discrimination (initial training) - Drug 2 - Incidental Cost | 4 | EA | 0.00 | |
| 3005 | Drug Discrimination (monthly maintenance of training drug) - Drug 1 - Assay Cost | 8 | EA | 0.00 | |
| 3006 | Drug Discrimination (monthly maintenance of training drug) - Drug 1 - Incidental Cost | 8 | EA | 0.00 | |
| 3007 | Drug Discrimination (monthly maintenance of training drug) - Drug 2 - Assay Cost | 8 | EA | 0.00 | |
| 3008 | Drug Discrimination (monthly maintenance of training drug) - Drug 2 - Incidental Cost | 8 | EA | 0.00 | |
| 3009 | Drug Discrimination of Test Drug - Assay Cost | 16 | EA | 0.00 | |
| 3010 | Drug Discrimination of Test Drug - Incidental Cost | 16 | EA | 0.00 | |
| 3011 | Pharmacokinetic Assay - Assay Cost | 10 | EA | 0.00 | |
| 3012 | Pharmacokinetic Assay - Incidental Cost | 10 | EA | 0.00 | |
| 3013 | Locomotor or another dose-finding assay (if applicable) - Assay Cost | 16 | EA | 0.00 | |
| 3014 | Locomotor or another dose-finding assay (if applicable) - Incidental Cost | 16 | EA | 0.00 | |
| 3015 | Drug Cost Not to Exceed | 16 | EA | $500.00 | 8,000.00 |
| TOTAL COST ($) | $8,000.00 |
ORDERING PERIOD 5
| PRICING SHEET TEMPLATE: ATTACHMENT 1 | |
| Title: | Evaluation of Abuse Potential of Hallucinogenic Substances Using In Vivo Pharmacological Studies |
| Agency: | Drug Enforcement Administration | ||||
| ORDERING PERIOD 5 | |||||
| CLIN Line Item | Assay | Quantity | Unit | Unit Price | Estimated Total Price |
| 4001 | Drug Discrimination (initial training) - Drug 1 - Assay Cost | 4 | EA | $0.00 | |
| 4002 | Drug Discrimination (initial training) - Drug 1 - Incidental Cost | 4 | EA | $0.00 | |
| 4003 | Drug Discrimination (initial training) - Drug 2 - Assay Cost | 4 | EA | $0.00 | |
| 4004 | Drug Discrimination (initial training) - Drug 2 - Incidental Cost | 4 | EA | $0.00 | |
| 4005 | Drug Discrimination (monthly maintenance of training drug) - Drug 1 - Assay Cost | 8 | EA | $0.00 | |
| 4006 | Drug Discrimination (monthly maintenance of training drug) - Drug 1 - Incidental Cost | 8 | EA | $0.00 | |
| 4007 | Drug Discrimination (monthly maintenance of training drug) - Drug 2 - Assay Cost | 8 | EA | $0.00 | |
| 4008 | Drug Discrimination (monthly maintenance of training drug) - Drug 2 - Incidental Cost | 8 | EA | $0.00 | |
| 4009 | Drug Discrimination of Test Drug - Assay Cost | 16 | EA | $0.00 | |
| 4010 | Drug Discrimination of Test Drug - Incidental Cost | 16 | EA | $0.00 | |
| 4011 | Pharmacokinetic Assay - Assay Cost | 10 | EA | $0.00 | |
| 4012 | Pharmacokinetic Assay - Incidental Cost | 10 | EA | $0.00 | |
| 4013 | Locomotor or another dose-finding assay (if applicable) - Assay Cost | 16 | EA | $0.00 | |
| 4014 | Locomotor or another dose-finding assay (if applicable) - Incidental Cost | 16 | EA | $0.00 | |
| 4015 | Drug Cost Not to Exceed | 16 | EA | $500.00 | $8,000.00 |
| TOTAL COST ($) | $8,000.00 |
File details come from the government source that posted it. Updated .